Literature DB >> 16514718

[Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial].

E F M Wouters, D S Postma, B Fokkens, W C Hop, J Prins, A F Kuipers, H R Pasma, C A J Hensing, E C Creutzberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16514718

Source DB:  PubMed          Journal:  Rev Port Pneumol        ISSN： 0873-2159


× No keyword cloud information.
  3 in total

Review 1.  Combined corticosteroid and long-acting beta₂-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease.

Authors:  Luis Javier Nannini; Phillippa Poole; Stephen J Milan; Rebecca Holmes; Rebecca Normansell
Journal:  Cochrane Database Syst Rev       Date:  2013-11-10

Review 2.  Combined corticosteroid and long-acting beta-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease.

Authors:  L Nannini; C J Cates; T J Lasserson; P Poole
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17

Review 3.  Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease.

Authors:  Kayleigh M Kew; Alieksei Seniukovich
Journal:  Cochrane Database Syst Rev       Date:  2014-03-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.